Side Effects

28 anonymous reports

The part no one tells you about GLP 1 the racing heart isn't only the drug. it's that you're barely eating, barely drinking, and fluid-empty so the reflex heart rate spike gets worse. I white-knuckled palpitations for weeks before someone pointed out I was chronically dehydrated. started actually drinking water and half of it settled down (not all. but half)

#319
GLP-1

My own N=1 PT-141, dosing 1.75mg, subQ, about 45 minutes before. onset half an hour to an hour. flushing, a little nausea, blood pressure ticks up for a bit all normal, all passes. . figured out the timing through trial and error and one very awkwardly-timed evening.

#317
PT-141

Everyone's racing to 12mg on reta, I stopped at 6. weight started coming off around 4 anyway, and the side effects at the top dose aren't worth the extra half-pound a week / you don't get a medal for suffering more / I'm holding here indefinitely and losing steady / the hero-dose crowd can have their heart palpitations.

#314
Retatrutide

the trials say nausea. reddit says something else entirely. thousands of us reporting the opposite of what Lilly measured appetite going UP, wired-not-tired insomnia, energy like a stimulant. 13,000 real users can't all be lying. the paper and the people don't match, and I trust the people.

#306

nausea. vomiting. constipation. burping I won't get into. 65% of people on sema get some kind of gut disaster and I got the full menu. lost the weight though. spent month one on the bathroom floor earning it.

#298
Semaglutide

62, no heart problems my whole life. two days after my tirz shot my heart went to 150 sitting on the couch and wouldn't come down. blood pressure 90 over 60. I told the ER it was probably just anxiety. they shocked my heart back into rhythm with paddles. new-onset atrial fibrillation, no other cause they could find, and it never came back once I stopped. I keep thinking about how close I came to calling it stress and going back to bed.

#290
Tirzepatide

planned the perfect PT-141 evening. candles, wine, timing to the minute. the nausea showed up first and stayed through the whole appetizer. romance killed by pharmacokinetics

#279
PT-141

nobody warned me about tirzepatide sulfur burps. i'm telling you now as a public service. rotten egg. out of nowhere. you're welcome and i'm so sorry

#276
Tirzepatide
Page 2 of 2
PreviousNext

community guides:

Peptide Side EffectsPeptides for RecoveryBest Peptide Stacks

related topics:

Peptide Side EffectsBest Peptide StacksPeptides for RecoverySourcing

Community Q&A

What side effects do peptide users most commonly report?
Side effect patterns in the archive vary sharply by compound class. GLP-1 agents (semaglutide, tirzepatide): nausea, constipation, fatigue, and GI discomfort are the most reported — most describe these as dose-dependent and manageable with slow titration. GH secretagogues (ipamorelin, CJC-1295): vivid dreams, water retention, and tingling (particularly hands) appear in a significant minority of accounts. Recovery peptides (BPC-157, TB-500): the side effect profile is notably thin — most accounts report no adverse effects at typical community doses. Melanocortin peptides (PT-141, melanotan): flushing, nausea, and spontaneous erections are consistently reported.
Are peptide side effects dangerous?
Based on community accounts, serious adverse events are rare and not well-represented in the archive. The more common side effects described — nausea, water retention, fatigue, injection site reactions — are typically described as manageable and dose-related. Accounts describing serious reactions (severe allergic response, hormonal disruption) exist but are a small fraction of reports. The absence of serious adverse event accounts should not be taken as evidence of safety — community reporting skews toward typical experiences, not outlier events. Anyone considering peptide use should consult a qualified medical provider.
How do people manage peptide side effects based on community accounts?
The most common management strategies described in the archive: for GLP-1 GI side effects, slow dose titration — staying at a low dose for 4–6 weeks before increasing — is the near-universal approach in accounts that successfully managed nausea. For GH secretagogue water retention, accounts describe reducing dose and timing injections away from meals. For injection site reactions, accounts describe rotating sites, warming the solution, and injecting slowly. For PT-141 flushing and nausea, accounts describe dosing 2–3 hours before rather than immediately before activity. The consistent pattern: side effects that prompted protocol abandonment were almost always addressed by adjustments that a more experienced user would have made from the start.
What are the most surprising side effects peptide users report?
Community accounts surface several side effects that users describe as unexpected. Vivid, cinematic dreams from GH secretagogues — particularly ipamorelin and MK-677 — are among the most consistently surprising, with accounts describing the experience as both striking and difficult to prepare for. PT-141's spontaneous erections at higher doses surprise users who expected a more controlled response. BPC-157 accounts occasionally describe a temporary increase in emotional sensitivity or mood change in the first 1–2 weeks. MK-677's appetite increase surprises users who expected it to passively improve body composition — several accounts describe struggling to control intake despite knowing intellectually that the compound increases ghrelin. GLP-1-associated muscle loss surprises users who expected fat-only reduction.